Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
Shandong Saito Biotechnology
Shandong Saito Biotechnology
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
Shandong Saito Biotechnology
Stock Price
¥16.5
2024-09-27
Market Capitalization
¥3.1 B
2024-09-27
Revenue
¥1.2 B
FY, 2023
Shandong Saito Biotechnology Summary
Company Summary
Overview
Shandong Saito Biotechnology (山东斋藤生物科技) is a company that is engaged in the research and development and production of steroid drug intermediates. Its products include neomycin sulfate, tetraene, androstenedione, acid depletion, etc.
Type
Public
Status
Active
Founded
2010
HQ
Heze, CN
|
view all locations
Website
https://www.sitobiotech.com/
Cybersecurity rating
Sectors
Healthcare
biotech
drug development
Homepage
Table of Contents
Locations
Financials
Competitors
Locations
View all
1 location detected
Heze, Shandong
HQ
China
Dingtao District
Report incorrect company information
Shandong Saito Biotechnology Financials
Summary Financials
Revenue (Q1, 2024)
¥241.3M
Gross profit (Q1, 2024)
¥66.5M
Net income (Q1, 2024)
¥3.7M
Cash (Q1, 2024)
¥351.3M
EBIT (Q1, 2024)
¥16.6M
Enterprise value
$5.1B
Competitors and Similar Companies
Walvax Biotechnology
Healthcare - Public
Serum Institute of India
Healthcare - Subsidiary
Plasma Industries
Healthcare - Private
Bicycle Therapeutics
Healthcare - Public
Compare competitors
Footer menu
Contact us
Facebook
Twitter
LinkedIn
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2024
Share price data provided by IEX
Back
to top